[Düsseldorf gonarthrosis study of orthokin].
Heyll
U
U
Abteilung Medizinische Beratung, Deutsche Krankenversicherung AG, Köln.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D015982:Bias; D001769:Blood; D001798:Blood Proteins / Q000008:administration & dosage* / Q000037:antagonists & inhibitors; D000529:Complementary Therapies; D016265:Conflict of Interest; D004311:Double-Blind Method; D005607:Fraud; D005858:Germany; D006801:Humans; D007270:Injections, Intra-Articular; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D020370:Osteoarthritis, Knee / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001798:Blood Proteins; D017472:Receptors, Interleukin-1